20/20 Biolabs Inc (AIDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||
| Net Income | -2,175 | N/A | -765 |
| Depreciation Amortization | 255 | N/A | 22 |
| Accounts receivable | -2 | N/A | 6 |
| Accounts payable and accrued liabilities | 112 | N/A | 111 |
| Other Working Capital | -69 | N/A | 125 |
| Other Operating Activity | 589 | 0 | 13 |
| Operating Cash Flow | $-1,289 | $N/A | $-488 |
| Cash Flows From Investing Activities | |||
| Purchase Sale Intangibles | -5 | N/A | N/A |
| Other Investing Activity | -5 | 0 | 0 |
| Investing Cash Flow | $-5 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Issued | 250 | N/A | 70 |
| Other Financing Activity | 4,237 | 0 | 192 |
| Financing Cash Flow | $4,487 | $N/A | $262 |
| Beginning Cash Position | 1,026 | N/A | 1,784 |
| End Cash Position | 4,219 | N/A | 1,558 |
| Net Cash Flow | $3,193 | $N/A | $-226 |
| Free Cash Flow | |||
| Operating Cash Flow | -1,289 | N/A | -488 |
| Free Cash Flow | -1,289 | 0 | -488 |